CD40LG and acute myeloid leukemia: We therefore screened sera from AML patients and normal donors for IgM- and IgG-reactivity against recombinant NDPKs (rNDPKs) from E. coli, Pseudomonas aeroginosa (P. aueruginosa), S. aureus, S. pneumoniae, K. pneumoniae, C. albicans and Candida glabrata (C. glabrata) and the human NDPKS (NM23-H1 & -H2) (Fig 1C and 1D).